US Federal Trade Commission: FTC approves final order settling charges that Novartis AG’s acquisition of Alcon, Inc. was anticompetitive in U.S. eye care market
MLex Summary: The US Federal Trade Commission has conditionally cleared Novartis' acquisition of Alcon. In order to overcome concerns that the proposed merger would have created a monopoly in the market...To view the full article, register now.
Already a subscriber? Click here to view full article